Clinical Trial Update: Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Xuezhikang versus atorvastatin on glucose metabolism in patients with dyslipidemia and prediabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Prediabetes

Drugs mentioned

• Lipitor (atorvastatin)
• Xuezhikang

Snippet

Sponsor: Heart Health Research Center | Conditions: Metabolism Disorder, Lipid, Metabolism Disorder, Glucose | Phase 4 | Status: COMPLETED